Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 496 AL 510

Anthocyanins Potentially Contribute to Defense against Alzheimer's Disease

Afzal M, Redha A, AlHasan R.

Molecules. 2019 Nov 22;24(23):4255. doi: 10.3390/molecules24234255.

Mega-Analysis of Gene Expression in Mouse Models of Alzheimer's Disease

Zhuang B, Mancarci BO, Toker L, Pavlidis P.

eNeuro. 2019 Dec 4;6(6):ENEURO.0226-19.2019. doi: 10.1523/ENEURO.0226-19.2019. Print 2019 Nov/Dec.

Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: implications for Alzheimer's disease

Choubey D.

J Neuroinflammation. 2019 Nov 26;16(1):236. doi: 10.1186/s12974-019-1639-5.

Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood

Lardenoije R, Roubroeks JAY, Pishva E, Leber M, Wagner H, Iatrou A, Smith AR, Smith RG, Eijssen LMT, Kleineidam L, Kawalia A, Hoffmann P, Luck T, Riedel-Heller S, Jessen F, Maier W, Wagner M, Hurlemann R, Kenis G, Ali M, Del Sol A, Mastroeni D, Delvaux E, Coleman PD, Mill J, Rutten BPF, Lunnon K, Ramirez A, van den Hove DLA.

Clin Epigenetics. 2019 Nov 27;11(1):164. doi: 10.1186/s13148-019-0755-5.

The use of Huperzia species for the treatment of Alzheimer's disease

Kim Thu D, Vui DT, Ngoc Huyen NT, Duyen DK, Thanh Tung B.

J Basic Clin Physiol Pharmacol. 2019 Nov 28;31(3):/j/jbcpp.2020.31.issue-3/jbcpp-2019-0159/jbcpp-2019-0159.xml. doi: 10.1515/jbcpp-2019-0159.

Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?

Ahn KC, Learman CR, Baker GB, Weaver CL, Chung PS, Kim HG, Song MS.

J Korean Med Sci. 2019 Dec 2;34(46):e297. doi: 10.3346/jkms.2019.34.e297.

Organotypic brain slice cultures to model neurodegenerative proteinopathies

Croft CL, Futch HS, Moore BD, Golde TE.

Mol Neurodegener. 2019 Dec 2;14(1):45. doi: 10.1186/s13024-019-0346-0.

[Alzheimer's disease therapy: challenges and perspectives.]

Orlov MA.

Adv Gerontol. 2019;32(4):639-651.

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease

Jia L, Piña-Crespo J, Li Y.

Mol Brain. 2019 Dec 4;12(1):104. doi: 10.1186/s13041-019-0525-5.

[Alzheimer's disease and singing: an application in mediated therapy]

Hamm S, Sudres JL, Menouer L, Brandibas G.

Soins Gerontol. 2019 Nov-Dec;24(140):15-19. doi: 10.1016/j.sger.2019.09.004.

[Mobile applications in alzheimer's disease. A systematic review of the literature]

Sánchez-Gutiérrez C, Ortega-Bastidas P, Cano-de-la-Cuerda R.

Rehabilitacion (Madr). 2019 Oct-Dec;53(4):247-275. doi: 10.1016/j.rh.2019.07.002. Epub 2019 Nov 18.

Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer's disease

Wirths O, Zampar S.

Expert Opin Ther Targets. 2019 Dec;23(12):991-1004. doi: 10.1080/14728222.2019.1702972. Epub 2019 Dec 12.

β-amyloid and Oxidative Stress: Perspectives in Drug Development

Caruso G, Spampinato SF, Cardaci V, Caraci F, Sortino MA, Merlo S.

Curr Pharm Des. 2019;25(45):4771-4781. doi: 10.2174/1381612825666191209115431.

Oxidative DNA Damage Signalling in Neural Stem Cells in Alzheimer's Disease

Kieroń M, Żekanowski C, Falk A, Wężyk M.

Oxid Med Cell Longev. 2019 Nov 13;2019:2149812. doi: 10.1155/2019/2149812. eCollection 2019.

Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis

Teixeira JP, de Castro AA, Soares FV, da Cunha EFF, Ramalho TC.

Molecules. 2019 Dec 3;24(23):4410. doi: 10.3390/molecules24234410.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias